Loading company…
Rocgene develops and manufactures molecular diagnostic instruments and products.
Rocgene develops molecular diagnostic instruments and reagents, including fluorescence quantitative PCR instruments, detection cartridges, and DNA kits. Its products are used in diagnostics, disease prevention, life sciences, and veterinary medicine. Founded in 2016, it is based in Beijing, China, and was recognized as a National High-tech Enterprise. In February 2026, it raised Series B+ funding.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in